{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:45:46Z","timestamp":1793821546836,"version":"4.6.1"},"update-to":[{"DOI":"10.1002\/14651858.cd002095.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,5,31]],"date-time":"2013-05-31T00:00:00Z","timestamp":1369958400000}}],"reference-count":110,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002095.pub5","type":"journal-article","created":{"date-parts":[[2013,5,28]],"date-time":"2013-05-28T14:13:55Z","timestamp":1369750435000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease"],"prefix":"10.1002","volume":"2013","author":[{"given":"Kirsten E","family":"Sigterman","sequence":"first","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Institut f\u00fcr Allgemeinmedizin \/ Institute of General Practice; Orleansstrasse 47 Munich Germany 81667"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"van Pinxteren","sequence":"additional","affiliation":[{"name":"Huisartsen Oog in Al; Handelstraat 55a Utrecht Utrecht Netherlands 3533GH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Bonis","sequence":"additional","affiliation":[{"name":"Tufts Medical Centre\/Division of Gastroenterology; Tufts Medical Centre; 800 Washington Street Box 63 Boston MA USA 02111"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Lau","sequence":"additional","affiliation":[{"name":"Brown University Public Health Program; Center for Evidence-based Medicine; 121 S. Main Street Providence RI USA 02912"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattijs E","family":"Numans","sequence":"additional","affiliation":[{"name":"VU University Medical Center; Department of General Practice and Elderly Care Medicine, EMGO Institute for Health and Care Research, and Alzheimer Center; Van der Boechorststraat 7 12 Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,5,31]]},"reference":[{"key":"10.1002\/14651858.CD002095.pub5-BIB0001|cit1","first-page":"2849","article-title":"A randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease","volume":"96","author":"Armstrong","year":"2001","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00004836-200308000-00008","article-title":"Pantoprazole rapidly improves health-related quality of life in patients with heartburn","volume":"37","author":"Par\u00e9","year":"2003","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1365-2036.2005.02466.x","article-title":"Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and H2-RA-start' management strategies in primary care - the CADET-HR Study","volume":"21","author":"Armstrong","year":"2005","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/bmj.318.7182.502","article-title":"Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine","volume":"318","author":"Bardhan","year":"1999","journal-title":"BMJ"},{"issue":"Suppl","key":"10.1002\/14651858.CD002095.pub5-BIB0005|cit5","first-page":"A65","article-title":"Symptomatic gastroesophageal reflux disease (GERD): intermittent treatment (IT) with omeprazole (OM) and ranitidine (RAN) as a strategy for management","volume":"112","author":"Bardhan","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0006|cit6","first-page":"19","article-title":"Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial","volume":"30","author":"Wiklund","year":"1998","journal-title":"Italian Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2036.1996.44186000.x","article-title":"Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis","volume":"10","author":"Bate","year":"1996","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0008|cit8","first-page":"A45","article-title":"Symptom relief with omeprazole in patients without unequivocal oesophagitis","volume":"37","author":"Bate","year":"1995","journal-title":"Gut"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1365-2036.1997.00198.x","article-title":"Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis","volume":"11","author":"Bate","year":"1997","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0016-5085(78)90778-3","article-title":"Cimetidine in the treatment of symptomatic gastroesophageal reflux. A double blind controlled trial","volume":"74","author":"Behar","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00004836-198006000-00008","article-title":"Cimetidine, metoclopramide, or placebo in the treatment of symptomatic gastroesophageal reflux","volume":"2","author":"Bright-Asare","year":"1980","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00042737-199802000-00004","article-title":"Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole","volume":"10","author":"Carlsson","year":"1998","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0013|cit13","first-page":"A93","article-title":"Gastroesophageal reflux disease (GERD) in primary care - an international placebo controlled study of different treatment strategies with omeprazole","volume":"110","author":"Dent","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1572-0241.1998.163_b.x","article-title":"Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease","volume":"93","author":"Castell","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-2036.2009.04013.x","article-title":"Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non-erosive reflux disease","volume":"29","author":"Fass","year":"2009","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD002095.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2036.2005.02468.x","article-title":"Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease","volume":"21","author":"Fujiwara","year":"2005","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1365-2036.1997.00185.x","article-title":"Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride","volume":"11","author":"Galmiche","year":"1997","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/11024159850191175","article-title":"Gastro-oesophageal reflux symptoms - clinical findings and effect of ranitidine treatment","volume":"Suppl 583","author":"Hallerback","year":"1998","journal-title":"European Journal of Surgery"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/bmj.319.7209.550","article-title":"Heartburn treatment in primary care: randomised, double blind study for 8 weeks","volume":"319","author":"Hatlebakk","year":"1999","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3109\/00365528609011116","article-title":"Double-blind crossover study of ranitidine and placebo in gastro-oesophageal reflux disease","volume":"21","author":"Johansson","year":"1986","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0022|cit21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/00365520310002157","article-title":"Symptom-relieving effect of esomeprazole 40 mg daily in patients with heartburn","volume":"38","author":"Johnsson","year":"2003","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0021|cit22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/0036552031002139","article-title":"One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease","volume":"38","author":"Johnsson","year":"2003","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1023\/A:1022812103923","article-title":"Reductions in symptom distress reported by patients with moderately severe, nonerosive gastroesophageal reflux disease treated with rabeprazole","volume":"44","author":"Damiano","year":"2003","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s10620-005-3000-3","article-title":"Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease","volume":"50","author":"Kahrilas","year":"2005","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1572-0241.2002.05769.x","article-title":"Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial","volume":"97","author":"Miner","year":"2002","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0002-9270(03)00015-7","article-title":"Rabeprazole-based therapy in the management of symptomatic gastroesophageal reflux disease","volume":"98","author":"Sloan","year":"2003","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1046\/j.1365-2036.2003.01771.x","article-title":"Esomeprazole resolves chronic heartburn in patients without erosive oesophagitis","volume":"18","author":"Katz","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/j.1572-0241.1999.01206.x","article-title":"Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole","volume":"94","author":"Havelund","year":"1999","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3109\/00365529709011212","article-title":"Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response","volume":"32","author":"Lind","year":"1997","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"A151","DOI":"10.1016\/0016-5085(95)23268-0","article-title":"The effect of omeprazole (ome) 20 mg and 10 mg daily on heartburn in patients with endoscopy negative reflux disease (enrd)","volume":"108","author":"Lind","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"A151","DOI":"10.1016\/0016-5085(95)23268-0","article-title":"Omeprazole (ome) improves quality of life (qol) in patients with endoscopy negative reflux disease (enrd)","volume":"108","author":"Lind","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJM197702172960702","article-title":"A controlled trial of metoclopramide in symptomatic gastroesophageal reflux","volume":"296","author":"McCallum","year":"1977","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1001\/archinte.160.12.1810","article-title":"Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis","volume":"160","author":"Richter","year":"2000","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1001\/archinte.160.12.1803","article-title":"Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease","volume":"160","author":"Richter","year":"2000","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2036.1991.tb00020.x","article-title":"Cimetidine suspension in patients with stage 0 gastro-oesophageal reflux disease","volume":"5","author":"Riemann","year":"1991","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2036.1991.tb00531.x","article-title":"Famotidine (20 mg) b.d. relieves gastro-oesophageal reflux symptoms in patients without erosive oesophagitis","volume":"5","author":"Robinson","year":"1991","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0037|cit37","first-page":"126","article-title":"Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study","volume":"41","author":"Rush","year":"1995","journal-title":"Journal of Family Practice"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1001\/archinte.1991.00400120040007","article-title":"Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study","volume":"151","author":"Sabesin","year":"1991","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0039|cit39","first-page":"1997","article-title":"Omeprazole as a diagnostic tool in gastroesophageal reflux disease","volume":"92","author":"Schenk","year":"1997","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/archinte.1987.00370080123022","article-title":"Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial","volume":"147","author":"Sontag","year":"1987","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"423","DOI":"10.5694\/j.1326-5377.2002.tb04882.x","article-title":"Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care","volume":"177","author":"Talley","year":"2002","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s00535-011-0402-1","article-title":"Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trial","volume":"46","author":"Tan","year":"2011","journal-title":"Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s00535-008-2214-5","article-title":"Efficacy and safety of omeprazole in Japanese patients with nonerosive reflux disease","volume":"43","author":"Uemura","year":"2008","journal-title":"Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000080130","article-title":"Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease","volume":"70","author":"Zyl","year":"2004","journal-title":"Digestion"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0045|cit45","first-page":"A45","article-title":"A comparison of omeprazole 10mg and 20mg om with ranitidine 150mg bd for the treatment of GORD in primary care","volume":"37","author":"Venables","year":"1995","journal-title":"Gut"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3109\/00365529709011211","article-title":"Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice","volume":"32","author":"Venables","year":"1997","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/gut.40.5.587","article-title":"Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux - the 'sensitive oesophagus'","volume":"40","author":"Watson","year":"1997","journal-title":"Gut"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000198884","article-title":"Cimetidine in gastro-oesophageal reflux","volume":"26","author":"Bennett","year":"1983","journal-title":"Digestion"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2165\/11295960-000000000-00000","article-title":"Dexlansoprazole modified release in erosive oesophagitis and non-erosive reflux disease","volume":"70","author":"Croxtall","year":"2010","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/ajg.2010.458","article-title":"The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD","volume":"106","author":"Fass","year":"2010","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/BF01345293","article-title":"Controlled trial of cimetidine in reflux esophagitis","volume":"25","author":"Fiasse","year":"1980","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0052|cit52","first-page":"21","article-title":"Cimetidine for the treatment of symptomatic gastro-oesophageal reflux","volume":"35","author":"Greaney","year":"1981","journal-title":"British Journal of Clinical Practice"},{"issue":"1","key":"10.1002\/14651858.CD002095.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1368-5031.2006.00768.x","article-title":"Long-term management of patients with symptoms of gastro-oesophageal reflux disease - a Norwegian randomised prospective study comparing the effects of esomeprazole and ranitidine treatment strategies on health-related quality of life in a general practitioners setting","volume":"60","author":"Hansen","year":"2006","journal-title":"International Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0054|cit54","first-page":"A149","article-title":"A randomized omeprazole controlled trial comparing famotidine, mosapride or teprenone in patients with uninvestigated dyspepsia- the J-focus study","volume":"136","author":"Haruma\u00a0K","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2036.2000.00712.x","article-title":"The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients","volume":"14","author":"Herwaarden","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD002095.pub5-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00535-008-2186-5","article-title":"A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease","volume":"43","author":"Hongo","year":"2008","journal-title":"Journal of Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD002095.pub5-BIB0057|cit57","first-page":"655","article-title":"Efficacy and safety of lansoprazole (AG-1749) 15 mg and 30 mg in Japanese patients with non-erosive reflux disease (NERD): A phase III multicenter, double-blind, placebo-controlled trial","volume":"36","author":"Hongo","year":"2008","journal-title":"Japanese Pharmacology and Therapeutics"},{"issue":"35","key":"10.1002\/14651858.CD002095.pub5-BIB0058|cit58","first-page":"1772","article-title":"Ranitidine therapeutically effective in functional dyspepsia with reflux-like symptoms","volume":"137","author":"Jebbink","year":"1993","journal-title":"Nederlands Tijdschrift Voor Geneeskunde"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2036.2010.04339.x","article-title":"Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances","volume":"32","author":"Johnson","year":"2010","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2036.1993.tb00073.x","article-title":"Cimetidine improves gerd symptoms in patients selected by a validated gerd questionnaire","volume":"7","author":"Johnsson","year":"1993","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/00365529850166149","article-title":"One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease","volume":"33","author":"Johnsson","year":"1998","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2036.2008.03877.x","article-title":"On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor","volume":"29","author":"Juul-Hansen","year":"2008","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2036.2010.04508.x","article-title":"Randomised clinical trial: A multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease","volume":"33","author":"Kinoshita","year":"2011","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3810\/pgm.2009.07.2019","article-title":"Lansoprazole 15 mg once daily for 14 days is effective for treatment of frequent heartburn: Results of 2 randomized, placebo-controlled, double-blind studies","volume":"121","author":"Kushner","year":"2009","journal-title":"Postgraduate Medicine"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00004836-198604000-00006","article-title":"Domperidone, metoclopramide, and placebo all give symptomatic improvement in gastroesophageal reflux","volume":"8","author":"Maddern","year":"1986","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/gut.35.4.447","article-title":"Effect of famotidine on oesophageal sensitivity in gastro-oesophageal reflux disease","volume":"35","author":"Marrero","year":"1994","journal-title":"Gut"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0067|cit67","first-page":"81","article-title":"Panum (pantoprazole) effectiveness in the treatment of patients with GERD","volume":"4","author":"Masharova","year":"2011","journal-title":"\u00c8ksperimental\u02b9na\u00e2 i klini\u010deska\u00e2 gastro\u00e8nterologi\u00e2"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1365-2036.2004.02243.x","article-title":"Classification of dyspepsia and response to treatment with proton-pump inhibitors","volume":"20","author":"Meineche-Schmidt","year":"2004","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1572-0241.2004.30089.x","article-title":"Empiric treatment with high and standard dose of omeprazole in general practice: 2-week randomized placebo-controlled trial and 12-month follow-up of health-care consumption","volume":"99","author":"Meineche-Schmidt","year":"2004","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0070|cit70","first-page":"497","article-title":"Randomized controlled trial: roxatidine vs omeprazole for non-erosive reflux disease","volume":"57","author":"Nakamura","year":"2010","journal-title":"Hepatogastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(78)91802-0","article-title":"Effect of cimetidine in symptomatic gastro-oesophageal reflux","volume":"2(8099)","author":"Powell-Jackson","year":"1978","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0072|cit72","first-page":"1766","article-title":"Omeprazole versus ranitidine or ranitidine\/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease","volume":"91","author":"Richter","year":"1996","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1046\/j.1365-2036.1999.00558.x","article-title":"Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis","volume":"13","author":"Richter","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0074|cit74","first-page":"1541","article-title":"Ranitidine in the long-term treatment of gastroesophageal reflux disease (gerd): a randomized double-blind trial","volume":"90","author":"McCallum","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0075|cit75","first-page":"519","article-title":"Do endoscopic findings influence response to H2 antagonist therapy for gastroesophageal reflux disease?","volume":"82","author":"Robinson","year":"1987","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"A447","DOI":"10.1016\/S0016-5085(09)62059-X","article-title":"Lansoprazole 15 mg rapidly treats frequent heartburn over 14 days in a self-treating population: Pooled analysis of 3 randomized, double-blind, placebo-controlled studies","volume":"136","author":"Scheiman","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/archinte.1995.00430160156016","article-title":"Empiric therapy for gastroesophageal reflux disease","volume":"155","author":"Schindlbeck","year":"1995","journal-title":"Archives of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD002095.pub5-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2036.2007.03410.x","article-title":"Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?","volume":"26","author":"Talley","year":"2007","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1477\u201388","DOI":"10.1111\/j.1572-0241.2005.40280.x","article-title":"A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia:The CADET-HN Study","volume":"100","author":"Veldhuyzen van Zanten","year":"2005","journal-title":"The American Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD002095.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2036.2007.03409.x","article-title":"One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study","volume":"26","author":"Zanten","year":"2007","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/gast.1997.v112.pm9178669","article-title":"Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis","volume":"112","author":"Chiba","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0082|cit82","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0083|cit83","first-page":"245","article-title":"Heartburn, oesophagitis and Barrett's oesophagus in self-medicating patients in general practice","volume":"50","author":"Corder","year":"1996","journal-title":"British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000007521","article-title":"Gastro-oesophageal reflux disease","volume":"59","author":"Dent","year":"1998","journal-title":"Digestion"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1572-0241.2005.41217.x","article-title":"Updated guidelines for the diagnosis and treatment of gastro-oesophageal reflux disease","volume":"100","author":"Devault","year":"2005","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/00365529609095544","article-title":"Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease","volume":"Supplement 221","author":"Dimenas","year":"1996","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/BF01540415","article-title":"Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis","volume":"35","author":"Galmiche","year":"1990","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"7414","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0089|cit89","unstructured":"Ip S Bonis P Tatsioni A Raman G Chew P Kupelnick B Comparative effectiveness of management strategies for gastroesophageal reflux disease Evidence Report\/Technology Assessment No. 1; Rockville, MD: Agency for Healthcare Research and Quality. December 2005"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/07853899509031939","article-title":"Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population","volume":"27","author":"Isolauri","year":"1995","journal-title":"Annals of Medicine"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0091|cit91","first-page":"125","article-title":"Cisapride versus ranitidine in the treatment of reflux esophagitis","volume":"35","author":"Janisch","year":"1988","journal-title":"Hepato-gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1136\/gut.30.11.1523","article-title":"Heartburn - the acid test","volume":"30","author":"Joelsson","year":"1989","journal-title":"Gut"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3109\/00365528609011128","article-title":"Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease","volume":"21","author":"Johansson","year":"1986","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3109\/00365528709011148","article-title":"Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease","volume":"22","author":"Johnsson","year":"1987","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0140-6736(90)90287-F","article-title":"Symptoms in gastro-oesophageal reflux disease","volume":"335","author":"Klauser","year":"1990","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/13814789909094270","article-title":"Gastro-oesophageal reflux disease in primary care. Comparison and evaluation of existing national guidelines and development of uniform European guidelines","volume":"5","author":"Kroes","year":"1999","journal-title":"European Journal of General Practice"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0097|cit97","first-page":"619","article-title":"A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome","volume":"51","author":"Lewin van den Broek","year":"2001","journal-title":"British Journal of General Practice"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0016-5085(97)70025-8","article-title":"Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota","volume":"112","author":"Locke","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0099|cit99","first-page":"403","article-title":"Cisapride and cimetidine in the treatment of erosive esophagitis","volume":"37","author":"Maleev","year":"1990","journal-title":"Hepato-gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/BF01071906","article-title":"Symptomatic gastroesophageal reflux: incidence and precipitating factors","volume":"21","author":"Nebel","year":"1976","journal-title":"American Journal of Digestive Diseases"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/archinte.158.21.2373","article-title":"Heartburn requiring frequent antacid use may indicate significant illness","volume":"158","author":"Robinson","year":"1998","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1572-0241.1999.00925.x","article-title":"Esophageal hypersensitivity may be a major cause of heartburn","volume":"94","author":"Rodriguez-Stanley","year":"1999","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/gut.37.4.457","article-title":"Reflux related symptoms in patients with normal oesophageal exposure to acid","volume":"37","author":"Shi","year":"1995","journal-title":"Gut"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0104|cit104","first-page":"933","article-title":"Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease?","volume":"63","author":"Tefera","year":"1997","journal-title":"American Surgeon"},{"key":"10.1002\/14651858.CD002095.pub5-BIB0105|cit105","first-page":"46","article-title":"Heartburn and globus in apparently healthy people","volume":"126","author":"Thompson","year":"1982","journal-title":"Canadian Medical Association Journal"},{"issue":"8","key":"10.1002\/14651858.CD002095.pub5-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus","volume":"101","author":"Vakil","year":"2006","journal-title":"American Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD002095.pub5-BIB0107|cit107","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002095","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","author":"Pinxteren","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD002095.pub5-BIB0108|cit108","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002095.pub2","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","author":"Pinxteren","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD002095.pub5-BIB0109|cit109","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002095.pub3","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","author":"Pinxteren","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD002095.pub5-BIB0110|cit110","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002095.pub4","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","author":"Pinxteren","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD002095.pub5\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:03:03Z","timestamp":1748822583000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002095.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Upper GI and Pancreatic Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,31]]},"references-count":110,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002095.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,31]]}}}